معرفی
Nana Lyu is a Postdoctoral Research Fellow in Nanobiotechnology at the School of Natural Sciences, Macquarie University, specializing in advanced nanomaterial development for biomedical diagnostics. With an h-index of 11 and 808 citations across 19 research outputs, her work bridges nanotechnology and clinical applications through innovative biosensing techniques.
Her research focuses on:
- Surface-Enhanced Raman Spectroscopy (SERS) for label-free biomolecular detection
- Nanoparticle-based platforms for DNA methylation analysis in cancer
- Liquid biopsy methodologies for colorectal carcinoma diagnostics
- Multiplex pathogen detection systems targeting bacterial infections
- Translation of nanomaterials into clinical diagnostic tools
Analysis of her 2024-2025 publications reveals a concentrated effort in developing SERS-PCR hybrid assays for epigenetic cancer markers and bacterial identification. Her work demonstrates consistent innovation in overcoming sensitivity limitations of traditional diagnostic methods, with strong emphasis on clinical applicability for early cancer detection and infectious disease management. The integration of gold nanoparticles and upconversion materials represents a core technical theme across her recent outputs.
Dr. Lyu contributed to the "Sydney Vital" project (2019-2020) focused on ctDNA molecular profiling for cancer therapy guidance. Her collaborative network includes Prof. Y. Wang, A. Rodger, and K.M. Alom across chemistry, biology, and engineering disciplines, though no formal student supervision is documented.
Her research operates within Macquarie University's interdisciplinary nanotechnology ecosystem, leveraging partnerships with medical research institutes to advance point-of-care diagnostic platforms through material science innovations.
